掌上微试 vs eOutcome
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
掌上微试
Read full descriptionHide full description
掌上微试是微试平台(www.WeTrial.com)开发的移动端应用,提供给微试平台的临床试验机构、临床试验伦理、临床试验申办方、CRO公司使用的一款临床试验项目管理移动工具,通过掌上微试随时随地进行项目文档管理,在线查阅项目文档,拍照上传(自动转换为PDF格式),实现项目文档的高效、方便快捷地归档和共享;查看临床项目概要,方案摘要,项目进度,入组统计,SAE;消息提醒;个人ID信息。 掌上微试把WeTrial平台临床试验各方(申办方、临床机构、科室、伦理、受试者等)连接起来,大家在一个共同信息平台内协同工作,实现临床试验项目管理、质量控制、沟通、共享的联动效应,促使整个临床试验更加高效。
eOutcome
Read full descriptionHide full description
太美医疗科技秉承“让好药触手可及”的使命,正在构筑未来医药行业运行的基础设施,从而令新药更快上市,保障患者用药安全,让好药易于获得,同时,降低患者的医疗负担。 掌上随访是太美医疗科技围绕电子知情和患者数据自填报场景,供患者在参与临床试验中使用的移动端应用。应用功能包含远程视频知情讲解,知情文档电子签名,电子日志、患者问卷、自我评估及其他数据收集表单填写等功能。应用旨在提高患者参与临床试验的便利度,减轻患者参与临床试验的负担,致力于成为“以患者为中心”的去中心化临床试验的重要一环。
Screenshots
Verdict
The clearest difference is update cadence: 掌上微试 at monthly against eOutcome's every 8 months. 掌上微试 also leads on device support. eOutcome's advantage is iOS requirement (11.0 vs 15.0). On price and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
掌上微试 ships an update monthly, eOutcome every 8 months. The most recent releases landed on September 23, 2026 and May 18, 2026 respectively.
| Parameter | 掌上微试 | eOutcome |
|---|---|---|
| Price | Free | Free |
| Update frequency | Monthly — better | Every 8 months |
| Ads | No | — |
| In-app purchases | No | No |
| Devices | iPhone, iPod — better | — |
| Requires iOS | 15.0 | 11.0 — better |
| Further details — not scored | ||
| Size | 73 MB | 100 MB |
| Age rating | 12+ | 17+ |
| Developer | Beijing CTSmed Co.,Ltd | Zhejiang Taimei Medical Technology Co., Ltd. |
In-app purchases
掌上微试
No in-app purchases
eOutcome
No in-app purchases









